Clinical Trial

Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsule in Diabetic Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-arm interventional clinical study, the primary objective is to assess the changes in the small intestinal (SI) metagenomic profile of in diabetic participants from baseline to midpoint and endpoint in response to the ONS intervention. The study population is Type 2 Diabetes (T2D) participants (n=30) who will ingest an Oral Nutritional Supplement (ONS) .
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-21; most recent amendment 2025-08-07.
Trial Details
NCT Number NCT06704022
Lead Sponsor Nimble Science Ltd.
Collaborators: Alberta Obesity Centre
Conditions Type 2 Diabetes
Enrollment 30 participants
Start Date 2025-09
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-11